Skip to content

Collection of data of patients treated for cancer from 6 centers

Network of Oncology Clinical Trials India (NOCI): Registry of Cancers - NOCI Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039233
Enrollment
5000
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

BIRAC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases with the diagnosis of a particular cancer type listed in annexure 2 and diagnosed within the study period [January 2015 to July 2021 (retrospective) and August 2021 onwards (prospective)]. The therapeutic management of patients is subject to current treatment recommendations and is determined solely by the attending physician. The data collected will be descriptive and no changes in standard of care will be done as part this study. 1.Patients with newly-diagnosed cancer or medical records of patients with cancers (for retrospective cohort) of any age group 2. Signed written informed consent for prospective entry

Exclusion criteria

Exclusion criteria: With respect to the primary purpose of the registry, which is observational data capture regarding cancer patients, no exclusion criteria are specified.

Design outcomes

Primary

MeasureTime frame
overall survival of cancersTimepoint: 5 years

Secondary

MeasureTime frame
Proportion of cancers not starting treatment or abandoning treatmentTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Prasanth Ganesan

JIPMER

pg1980@gmail.com9444216310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026